Management of the axilla in women with breast cancer

Breast

Volumn 16, Issue 2, 2007, Pages 130-136

  Benson, J R ^b   Querci della Rovere, G ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Axilla; Breast cancer; Dissection; Sampling; Sentinel node

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL TIME; SYSTEMATIC REVIEW;

EID: 33947654934     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.06.003     Document Type: Article

References (25)

1. Fisher B., Wolmark N., Redmond C., Deutsch M., and Fisher E.R. Findings from NSABP Protocol No B-04: comparison of radical mastectomy with alternative treatments. II The clinical and biological significance of medial-central breast cancers. Cancer 48 (1981) 1863-1872
2. Baum M., and Coyle P.J. Simple mastectomy for early breast cancer and the behaviour of the untreated axillary nodes. Bull Cancer 64 (1977) 603-610
3. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 109-116
4. Chetty U., Jack W., Prescott R.J., Tyler C., and Rodger A. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg 87 (2000) 969-970
5. Rosen P.P., Saigo P.E., Braun D.W., et al. Prognosis in stage 2 (T1N1M0) breast cancer. Ann Surg 194 (1981) 576-584
6. Saiz E., Toonlel R., Poppit R.J., and Robinson M.J. Infiltrating breast carcinoma smaller than 0.5 centimeters. Cancer 85 (1999) 2206-2211
7. Maibenco D.C., Weiss L.K., Pawlish K.S., et al. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 85 (1999) 1530
8. Greco M., Agresti R., and Cascinelli N. Breast cancer patients treated without axillary surgery: clinical implications and biological analysis. Ann Surg 232 (2000) 1-7
9. Epstein R.J. Routine or delayed axillary dissection for primary breast cancer?. Eur J Cancer 31A (1995) 1570-1573
10. Cady B., Stone M.D., and Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218 (1993) 338-347
11. della Rovere GQ, Bonomi R, Ashley S, Benson JR. Can axillary staging be aovided in a selected group of women with small invasive breast tumours? Eur J Surg Oncol 2006; published online, doi:10.1016/j.ejs.2006.04.016.
12. EBCTCG. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352 (1998) 930-942
13. Vaidja J., Dewar J.A., Brown D.C., and Thompson A.M. A mathematical model for the effect of a false negative sentinel node biopsy on breast cancer mortality: a tool for every day use. Breast Cancer Res 7 (2005) 225-227
14. Macmillan R.D., and Blamey R.W. The case for axillary sampling. Adv Breast Cancer 1 (2004) 9-10
15. Hoar F.J., and Stonelake P.S. A prospective study of the value of axillary node sampling in addition to sentinel node biopsy in patients with breast cancer. Eur J Surg Oncol 29 (2003) 526-531
16. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., Boolbol S.K., Fey J.V., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
17. Macmillan R.D., Rampaul R.S., and Blamey R.W. Preoperative ultrasound-guided node biopsy and sentinel node augmented node sampling is best practice. Eur J Cancer 39 Suppl. 1 (2003) 23
18. Mansel R. Sentinel node biopsy versus standard axillary treatment: results of the randomised multicenter UK ALMANAC Trial. Breast cancer Res Treat 88 (2004) S13
19. Tew K., Irwing L., Matthews A., Crowe P., and Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92 (2005) 1068-1080
20. McCarter M.D., Yeung H., Fey J., et al. The breast cancer patient with multiple sentinel nodes: when to stop. J Am Coll Surg 192 (2001) 692-697
21. Steel R.J., Forrest A.P.M., and Chetty U. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomised trial. Br J Surg 72 (1985) 368-369
22. Kennedy R.J., Kollias J., Gill P.G., Bochner M., Coventry B.J., and Farshid G. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 90 (2003) 1349-1353
23. Dabbs D.J., Fung M., Landsittel D., McManus K., and Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumour burden. Breast J 10 (2004) 101-105
24. Wheatley D., Adwani A., Ebbs S., Hanson J., Ross G., Sharma A.K., et al. Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast. Clin Oncol R Coll Radiol 17 (2005) 32-38
25. Cserni G., Gregori D., Merletti F., Sapino A., Mano M.P., Ponti A., et al. Meta-analysis of non sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 9 (2004) 1245-1252